PRECISION: Canadian guidelines for polycythemia vera (PV) management
PRECISION, a national program designed to assess management of PV in Canadian daily practice, has published a series of recommendations on PV management
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms (MPN) Group.
Clin Lymphoma Myeloma Leuk. 2015 Aug 7. pii: S2152-2650(15)01098-8.
Dr. Vikas Gupta of the Princess Margaret Cancer Centre in Toronto speaks at the U.S. Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2015 conference in Alexandria, VA.
Dr. Vikas Gupta of the Princess Margaret Cancer Centre in Toronto and Dr. Rami S. Komrokji of the Moffitt Cancer Center in Tampa discuss their individual approaches that consider patient wishes and goals, type of donor, and disease risk in their decisions to perform stem cell transplants upfront or to delay them until after JAK2 inhibitor therapy.
Dr. Vikas Gupta talks about how the generous funding received from Elizabeth and Tony Comper will enable Princess Margaret Cancer Centre to develop a world-class program for the treatment of myeloproliferative neoplasms (MPNs)—a rare type of blood cancer. September 25, 2015.
Dr. Vikas Gupta, invited speaker, Queen’s University, Kingston, Ontario. November 3, 2015.
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms (MPN) Group
Dr. Shireen Sirhan. Addressing the Canadian MPN National Advisory Group, Vancouver, British Columbia. October 2, 2015.
Dr. Vikas Gupta, invited speaker, SOHO 2015 Annual Meeting (Society of Hematologic Oncology), Houston, Texas. September 2015.
With 12,000+ monthly readers, MPNforum is the most widely followed independent international online monthly magazine focused on myeloproliferative neoplasm patients and caregivers. The magazine, and its companion MPN Quarterly Journal, are open source publications entirely managed and staffed by patients and caregivers with the volunteer participation of scientists, hematologists and healthcare providers.
MPN Updates for iPhone®, iPad® and iPod Touch® is an interactive digital publication that focuses on the diagnosis and treatment of MPN disease states. The easy-to-read, digital flipbook format provides awareness of emerging therapeutic agents and their impact on patient outcomes. This newsletter is sponsored by Incyte Corp. through a third-party independent grant.
An independent newspaper that provides timely and relevant news and commentary about clinical developments in the field of hematology.
The MPN eSIMPLE app provides data, resources, and guidance to assist Canadian physicians in their daily management of patients with myeloproliferative neoplasm (MPNs).
The goal is to guide physicians in selecting the most appropriate therapeutic approach for each of their MPN patients and to standardize management strategies across the country.
The app can be used using the MPN eSIMPLE website or downloaded